A new law in Florida, CS/CS/SB 1768, allows physicians to market and administer stem cell therapies that have not been approved by the U.S. Food and Drug Administration (FDA) for orthopedic conditions, wound care and pain management. The law, which took effect on July 1, 2025, charts new territory in the decades-long debate over whether and when physicians can administer treatments with stem cells, especially if those treatments have not been approved by the FDA….
By: Holland & Knight LLP
By: Holland & Knight LLP
